Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 2;497(7447):137-41.
doi: 10.1038/nature12120. Epub 2013 Apr 21.

Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide

Arun K Shukla  1 , Aashish Manglik, Andrew C Kruse, Kunhong Xiao, Rosana I Reis, Wei-Chou Tseng, Dean P Staus, Daniel Hilger, Serdar Uysal, Li-Yin Huang, Marcin Paduch, Prachi Tripathi-Shukla, Akiko Koide, Shohei Koide, William I Weis, Anthony A Kossiakoff, Brian K Kobilka, Robert J Lefkowitz
Affiliations

Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide

Arun K Shukla et al. Nature. .

Abstract

The functions of G-protein-coupled receptors (GPCRs) are primarily mediated and modulated by three families of proteins: the heterotrimeric G proteins, the G-protein-coupled receptor kinases (GRKs) and the arrestins. G proteins mediate activation of second-messenger-generating enzymes and other effectors, GRKs phosphorylate activated receptors, and arrestins subsequently bind phosphorylated receptors and cause receptor desensitization. Arrestins activated by interaction with phosphorylated receptors can also mediate G-protein-independent signalling by serving as adaptors to link receptors to numerous signalling pathways. Despite their central role in regulation and signalling of GPCRs, a structural understanding of β-arrestin activation and interaction with GPCRs is still lacking. Here we report the crystal structure of β-arrestin-1 (also called arrestin-2) in complex with a fully phosphorylated 29-amino-acid carboxy-terminal peptide derived from the human V2 vasopressin receptor (V2Rpp). This peptide has previously been shown to functionally and conformationally activate β-arrestin-1 (ref. 5). To capture this active conformation, we used a conformationally selective synthetic antibody fragment (Fab30) that recognizes the phosphopeptide-activated state of β-arrestin-1. The structure of the β-arrestin-1-V2Rpp-Fab30 complex shows marked conformational differences in β-arrestin-1 compared to its inactive conformation. These include rotation of the amino- and carboxy-terminal domains relative to each other, and a major reorientation of the 'lariat loop' implicated in maintaining the inactive state of β-arrestin-1. These results reveal, at high resolution, a receptor-interacting interface on β-arrestin, and they indicate a potentially general molecular mechanism for activation of these multifunctional signalling and regulatory proteins.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Fab30 specifically recognizes and stabilizes an active state of β-arrestin1
a, G protein coupled receptors are phosphorylated following activation, leading to the binding of arrestins. Interactions between the phosphorylated receptor and β-arrestin1 lead to β-arrestin1 activation and the subsequent blockade of G protein signaling and initiation of β-arrestin1 signaling pathways. b, Interaction between β-arrestin1 and Fab30 requires the presence of V2Rpp in a size exclusion assay. c, The formation of a complex between a GPCR and β-arrestin allosterically leads to an enhanced affinity of agonist for the receptor, termed the “high agonist affinity state.” Therefore, the fraction of receptor in the high agonist affinity state reflects the extent of complex formation between receptor and β-arrestin. In a radioligand competition binding assay using 125I-cyanopindolol as the probe and the agonist isoproterenol (Iso) as the competitor, β-arrestin1 alone shifts a small portion (14%) of receptors into the high agonist affinity state. Fab30 significantly amplifies this effect (31%) (n=3, p<0.0001 in F test). d, In a pull-down assay, phosphorylated β2-V2R chimera shows appreciable binding to β-arrestin1 only in the presence of Fab30. e, Overall structure of the β-arrestin1:V2Rpp:Fab30 complex.
Figure 2
Figure 2. Conformational changes associated with β-arrestin1 activation
The structures of inactive β-arrestin1 (PDB ID: 1G4M chain A, light blue) and active β-arrestin1 (gold) were aligned on the N-domains. The β-arrestin1 carboxy terminus is highlighted in dark blue. a, A substantial rotation and translation of the C-domain relative to the N-domain occurs upon activation. The rotation axis is indicated as a solid black line. b, View of C-domain rotation along the axis. c, N-domain of inactive arrestin, highlighting important regions. d, Active β-arrestin1 in the same orientation, showing V2Rpp in green. Phosphorylated residues are highlighted as sticks. e, The overall structure of inactive β-arrestin1 (PDB ID: 1G4M, chain A), with loops from all inactive β-arrestin1 structures superimposed (grey loops). The active conformation of these loops (orange loops) deviates from all inactive structures.
Figure 3
Figure 3. V2Rpp interactions with β-arrestin1
a, Overall view of β-arrestin1, with regions of interest in boxes. Select charge-charge contacts are shown in dotted lines. b, V2Rpp (green) displaces the inactive finger loop (light blue), causing it to adopt an extended conformation in the active state (gold). c, In the inactive conformation, the β-arrestin1 carboxy-terminal β strand (dark blue) lies along the N-domain in the “three element” interaction network. d, Upon activation, this strand is displaced by the carboxy terminus of the V2Rpp, which engages in extensive charge-charge interactions through phosphorylated residues. e, The “polar core” of β-arrestin1 is thought to be a critical stabilizer of the inactive state. f, Upon V2Rpp binding, the carboxy-terminal strand residue Arg393 is displaced, and its interaction partner D297 undergoes a large movement together with the rest of the lariat loop.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3:639–650. doi:10.1038/nrm908. - PubMed
    1. Hepler JR, Gilman AG. G proteins. Trends Biochem Sci. 1992;17:383–387. - PubMed
    1. Freedman NJ, Lefkowitz RJ. Desensitization of G protein-coupled receptors. Recent Prog Horm Res. 1996;51:319–351. discussion 352-313. - PubMed
    1. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science. 2005;308:512–517. doi:10.1126/science.1109237. - PubMed
    1. Nobles KN, Guan Z, Xiao K, Oas TG, Lefkowitz RJ. The active conformation of beta-arrestin1: direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2. J Biol Chem. 2007;282:21370–21381. doi:10.1074/jbc.M611483200. - PubMed

Publication types

MeSH terms

Associated data